• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Stanford Aging and Ethnogeriatrics Research Center (SAGE Center)

Stanford Aging and Ethnogeriatrics Research Center (SAGE Center)

Ace Aging

  • LinkedIn
  • Twitter
  • Home
  • About Us
  • Awardees
  • Faculty
  • Research Methodology Podcasts
  • Research
  • Contact Us

SAGE awardees

Fátima Rodriguez, MD, MPH

Assistant Professor
Department of Medicine – Med/Cardiovascular Medicine

https://profiles.stanford.edu/85681

Fátima Rodriguez, MD, MPH is a practicing general and preventive cardiologist and a health disparities researcher. Dr. Rodriguez attended the University of Pennsylvania, where she graduated summa cum laude with a degree in the Biological Basis of Behavior. Prior to medical school, she worked as a certified Spanish medical interpreter in Philadelphia hospitals. She then received her medical degree from Harvard Medical School and her MPH from the Harvard School of Public Health as a Zuckerman Fellow from the Harvard Kennedy School’s Center for Public Leadership. She completed internal medicine residency at Brigham and Women’s Hospital and Harvard University.

Dr. Rodriguez arrived to Stanford University in 2014 as a cardiovascular medicine fellow and was selected to serve as Chief Fellow. Her research interests include a range of issues relating to racial and ethnic disparities in guideline adherence, cardiovascular disease prevention, health promotion and leveraging technology to improve the care of diverse patients. She has authored over 70 peer-reviewed publications on these topics and has been a two-time winner of Stanford University’s Alderman Award for Excellence in Clinical Research. Her work is funded by a career development award from the National Heart, Lung, and Blood Institute and the McCormick Galiban Faculty Award. Dr. Rodriguez is the Research Director for an innovative telemedicine program in cardiology, CardioClick, and Director of Population Health for Stanford’s Systems Utilization Research. As a Fellow of the American College of Cardiology and the American Heart Association, she holds multiple leadership roles aimed at improving gender and racial/ethnic diversity in cardiology. Dr. Rodriguez serves as an Associate Editor for the New England Journal of Medicine Journal Watch Cardiology.

SAGE Project: Secondary prevention of cardiovascular disease in the elderly

Dr. Rodriguez’s project will study the current practice patterns for low-density lipoprotein cholesterol (LDL-C) lowering among adults over 75 years of age in a large multiethnic electronic health record-based cohort. The current American College of Cardiology/American Heart Association guidelines on management of blood cholesterol explicitly note the lack of data for the benefit of intensive lipid-lowering among older adults, who have not been included in the clinical trials that guide our evidence base. Dr. Rodriguez will also identify patient-level predictors of moderate and high-intensity statin use among high risk patients with atherosclerotic cardiovascular disease.

Previous Post: « Carolyn Rodriguez, MD, PhD
Next Post: Kacie Deters, PhD »

Ace Aging

Footer

Stanford Medicine

  • About
  • School Administration
  • Contact
  • Maps & Directions
  • Jobs

 

  • Basic Science Departments
  • Clinical Science Departments
  • Academic Programs
  • Diversity Programs

Healthcare

  • Find a physician
  • Clinical Trials
  • Patient Information
  • Contact

Related

  • Ethnogeriatrics
  • Salud (Spanish Health Site)
  • Project Respect
  •   Find People
  •   Visit Stanford
  •   Search Clinical Trials
  •   Give a Gift

Copyright © 2023 Stanford Medicine
Privacy Policy | Terms of Use

    Next-Generation Artificial Intelligence for Diagnosis: From Predicting Diagnostic Labels to "Wayfinding"

    Julia Adler-Milstein, PhD1; Jonathan H. Chen, MD, PhD; Gurpreet Dhaliwal, MD

    Improving the diagnostic process is a quality and safety priority.With the digitization of health records and rapid expansion of health data, the cognitive demand on the diagnostician has increased. The use of artificial intelligence (AI) to assist human cognition has the potential to reduce this demand and associated diagnostic errors. However, current AI tools have not realized this potential, due in part to the long-standing focus of these tools on predicting final diagnostic labels instead of helping clinicians navigate the dynamic refinement process of diagnosis. This Viewpoint highlights the importance of shifting the role of diagnostic AI from predicting labels to “wayfinding” (interpreting context and providing cues that guide the diagnostician).